Financial Year |
March 31 2023 |
Monetary Funds |
1,624,093,583.06 |
Held-for-trading Financial Assets |
307,466,079.93 |
Notes Receivable |
-- |
Accounts Receivable |
139,141,798.19 |
Advances to Suppliers |
7,114,625.22 |
Other Receivables |
32,877,529.64 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
308,064,640.95 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
10,346,662.05 |
Total Current Assets |
2,429,104,919.04 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
29,733,619.79 |
Investment Properties |
75,586,323.00 |
Fixed Assetes |
522,611,834.15 |
Under-construction Projects |
264,134,571.82 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
169,270,898.45 |
R&D expenses |
7,388,774.92 |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
9,593,974.96 |
Other Non-Current Assets |
54,039,947.84 |
Sub-Total of Non-Current Assets |
1,305,545,397.57 |
Total Assets |
3,734,650,316.61 |
Short-Term Loans |
322,290,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
45,034,995.78 |
Accounts Payable |
74,514,718.76 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
101,688,177.78 |
Taxes Payable |
7,168,761.52 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
6,417,926.54 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
6,084,565.17 |
Other Current Liabilities |
315,447.51 |
Sub-Total of Current Liabilities |
1,172,478,513.19 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
3,031,069.53 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
80,924,000.10 |
Total Liabilities |
1,253,402,513.29 |
Paid-In Capital(Or Share Stock) |
405,890,000.00 |
Capital Surplus |
939,135,595.59 |
Surplus Reserve |
137,764,186.99 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,001,056,971.34 |
Minority Stockholder's Interest |
-2,598,950.60 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,483,846,753.92 |
Owner's Equity(Stockholder's Equity) |
2,481,247,803.32 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
3,734,650,316.61 |